About Nexcelom Bioscience
Nexcelom Bioscience is a company based in Lawrence (United States) founded in 2003 was acquired by PerkinElmer in May 2021. Nexcelom Bioscience offers products and services including Cellometer Ascend, Cellaca PLX, and ViaStain AOPI. Nexcelom Bioscience operates in a competitive market with competitors including Halo Labs, Spheryx, Biotrack, TACount and Spectradyne, among others.
- Headquarter Lawrence, United States
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Revvity, Inc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
-
Investors
PerkinElmer
& 1 more
-
Employee Count
Not available
-
Acquired by
PerkinElmer
(May 12, 2021)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Nexcelom Bioscience
Nexcelom Bioscience offers a comprehensive portfolio of products and services, including Cellometer Ascend, Cellaca PLX, and ViaStain AOPI.
Device for fast and accurate cell counting in research applications
High-throughput system for assessing cell health and viability
Staining solution for cell viability and analysis in assays
People of Nexcelom Bioscience
Unlock access to complete
Unlock access to complete
Funding Insights of Nexcelom Bioscience
Investors in Nexcelom Bioscience
Nexcelom Bioscience has secured backing from 2 investors, including venture fund and institutional investors. Prominent investors backing the company include PerkinElmer and Ampersand Capital Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Ampersand Capital Partners is focused on investments in healthcare and life sciences.
|
Locked | Locked | Locked | |
|
Medical instruments and supplies are manufactured and provided for healthcare.
|
Locked | Locked | Locked |
Investor details for Nexcelom Bioscience
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Nexcelom Bioscience
Investment portfolio details for Nexcelom Bioscience
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Nexcelom Bioscience
Detailed financials for Nexcelom Bioscience
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Nexcelom Bioscience Comparisons
Peer comparison for Nexcelom Bioscience
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Nexcelom Bioscience
Nexcelom Bioscience operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Halo Labs, Spheryx, Biotrack, TACount and Spectradyne, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Developer of subvisible particle analyzer for life science and materials applications
|
|
| Locked | Locked | Locked |
Analytical instruments company developing instruments for non-destructive, quantitative measurements of suspended particles
|
|
| Locked | Locked | Locked |
Rapid microbial detection and identification system
|
|
| Locked | Locked | Locked |
Specializes in imaging-based technology for microbiological testing.
|
|
| Locked | Locked | Locked |
Nano-particle counters are manufactured for research and biomedical uses.
|
Detailed competitors of Nexcelom Bioscience
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Nexcelom Bioscience
Complete news archive for Nexcelom Bioscience
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Nexcelom Bioscience
Nexcelom Bioscience was founded in 2003 and raised its 1st funding round 15 years after it was founded.
Nexcelom Bioscience is headquartered in Lawrence, United States. It is registered at Lawrence, Kansas, United States.
Founded in 2003 and based in Lawrence, United States, operations focus on the biotechnology sector through the development, manufacturing, and marketing of image-based cytometry tools. Products such as the Cellometer automated counters and Celigo imaging cytometer are utilized for cell analysis and viability assessments in both attached and suspension cells. Fluorescent reagents, kits, disposable hemocytometers, counting chambers, and low-adhesion plates are also provided to support cell-based assays.
Nexcelom Bioscience's top competitors include Halo Labs, Spheryx and Spectradyne.
Nexcelom Bioscience offers Cellometer Ascend, Cellaca PLX, and ViaStain AOPI.
Nexcelom Bioscience has 2 investors. Key investors include PerkinElmer, and Ampersand Capital Partners.